GIBH-130 is primarily utilized in the field of biomedical research, particularly in the study of cellular signaling pathways. It is often employed as a selective inhibitor to investigate the role of specific proteins or enzymes in biological processes. Researchers use it to explore its effects on cell proliferation, apoptosis, and other cellular functions, which can provide insights into disease mechanisms and potential therapeutic targets. Its application is particularly relevant in cancer research, where it helps in understanding the molecular basis of tumor growth and progression. Additionally, GIBH-130 is used in pharmacological studies to assess its efficacy and safety as a potential drug candidate for various diseases.